The NHS is using new treatments to treat COVID-19 outside of hospital.
These free treatments need to be given quickly after infection. They can help some people manage their symptoms and reduce the risk of becoming seriously unwell.
Each integrated care system (ICS) has established a local COVID-19 medicine delivery unit (CMDU) to offer treatment for COVID-19 in non-hospital settings.
More information for NHS staff is available.
After considering the latest scientific evidence, the 4 UK Chief Medical Officers have set out the criteria outlining who can access the treatments.
People who have the following conditions may be suitable:
- Down's syndrome
- sickle cell disease
- HIV or AIDS
- chronic kidney disease (CKD) stage 4 or 5
- certain types of cancer
- had certain types of chemotherapy in the last 12 months
- had radiotherapy in the last 6 months
- had an organ transplant
- a severe liver condition (such as cirrhosis)
- a rare condition affecting the brain or nerves (multiple sclerosis, motor neurone disease, Huntington’s disease or myasthenia gravis)
- certain autoimmune or inflammatory conditions (such as rheumatoid arthritis or inflammatory bowel disease)
- a condition or treatment that makes you more likely to get infections
Find out more about this policy.
Eligibility policy and supply of COVID-19 treatments is led by the UK Department of Health and Social Care and implementation in England is led by NHS England and Improvement.
How the process works
Some patients will receive a letter letting them know they may be eligible for treatment. At this stage, there is no action for the patient. However, patients are advised to accurately provide their NHS number and postcode when they register a lateral flow or PCR test. This will enable the NHS to contact them about the treatment if they test positive.
If an individual in these groups later tests positive, they will be sent a text message and email with information about next steps.
Within a day of testing positive, they will also receive a call from a CMDU to arrange a clinical assessment. This will determine whether they are eligible for treatment.
Last edited: 19 May 2022 9:14 am